ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
83.075
-0.66%
US Dollar vs AUD
1.51344
-0.55%
Bitcoin
61,899.21
4.70%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Viking Therapeutics Inc (VKTX)

  7. Viking Therapeutics Inc (VKTX) News

VKTX Viking Therapeutics Inc

76.72
0.96 (1.27%)
Last Updated: 03:24:54
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Viking Therapeutics Inc VKTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.96 1.27% 76.72 03:24:54
Open Price Low Price High Price Close Price Previous Close
74.40 72.88 77.68 75.76
more quote information »

Recent News

Date Time Source Heading
25/4/202406:05PRNUSViking Therapeutics Reports First Quarter 2024 Financial..
24/4/202421:31IHMARKETNEWSU.S. Futures Display Mixed Results Amid Earnings, WTI and..
18/4/202406:05PRNUSViking Therapeutics to Report Financial Results for First..
26/3/202422:03PRNUSViking Therapeutics Announces Results from Phase 1 Clinical..
05/3/202411:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202411:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:52EDGAR2Form 8-K - Current report
05/3/202408:45PRNUSViking Therapeutics Announces Closing of Public Offering of..
02/3/202408:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202412:50PRNUSViking Therapeutics Announces Pricing of $550 Million Public..
28/2/202409:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202408:19PRNUSViking Therapeutics Announces Proposed Public Offering of..
27/2/202423:04EDGAR2Form 8-K - Current report
27/2/202423:03PRNUSViking Therapeutics Announces Positive Top-Line Results from..
10/2/202412:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:01EDGAR2Form 144 - Report of proposed sale of securities
09/2/202411:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202411:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202408:56EDGAR2Form 144 - Report of proposed sale of securities
09/2/202408:33EDGAR2Form 144 - Report of proposed sale of securities
08/2/202409:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/2/202409:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/2/202408:09EDGAR2Form 8-K - Current report
08/2/202408:05PRNUSViking Therapeutics Reports Fourth Quarter and Year-End 2023..
01/2/202412:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202409:32EDGAR2Form 144 - Report of proposed sale of securities
01/2/202408:05PRNUSViking Therapeutics to Report Financial Results for Fourth..
31/1/202413:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202408:23EDGAR2Form 144 - Report of proposed sale of securities
20/1/202412:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:36EDGAR2Form 144 - Report of proposed sale of securities
05/1/202413:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202413:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202413:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202308:02PRNUSViking Therapeutics Presents New Data from Phase 2b VOYAGE..
03/11/202307:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
26/10/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202307:24EDGAR2Form 8-K - Current report
26/10/202307:05PRNUSViking Therapeutics Reports Third Quarter 2023 Financial..
23/10/202322:05PRNUSViking Therapeutics Announces Completion of Enrollment in..
19/10/202307:05PRNUSViking Therapeutics to Report Financial Results for Third..
19/10/202300:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
19/10/202300:03IHMARKETNEWSWednesday’s Wall Street Highlights: ASML, Nvidia, United..
18/10/202307:05PRNUSViking Therapeutics Presents New Data from Phase 1 Clinical..
11/10/202307:05PRNUSViking Therapeutics to Highlight Data from Phase 1 Clinical..
08/9/202306:05PRNUSViking Therapeutics to Participate at Upcoming Investor..
06/9/202321:03PRNUSViking Therapeutics Announces Initiation of Phase 2 VENTURE..
27/7/202307:26EDGAR2Form S-3ASR - Automatic shelf registration statement of..
27/7/202306:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202306:23EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
VKTX
Viking Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved